RecruitingNot ApplicableNCT07473232

Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoarthritis. (KOA PRP ACS)


Sponsor

Pamukkale University

Enrollment

60 participants

Start Date

Apr 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The effects of single dose injection of platelet rich plasma or conditioned serum in the knee joint in patients with knee osteoarthritis will be compared


Eligibility

Min Age: 40 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Autologous Platelet-Rich Plasma (PRP) and a drug called Conditioned serum (CS) for people with conditioned serum, knee arthritis, osteoarthritis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAutologous Platelet-Rich Plasma (PRP)

Autologous Platelet-Rich Plasma (PRP) will be injected intra-articularly in patients with knee osteoarthritis

DRUGConditioned serum (CS)

Autologous conditionedserum (CS) will be injected intra-articularly in patients with knee osteoarthritis


Locations(1)

Pamukkale University Hospital

Pamukkale, Denizli, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07473232


Related Trials